Geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), threatens significant vision loss for ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

Opens in a new tab or window Geographic atrophy (GA), associated with advanced stages of age-related macular degeneration (AMD), exacerbates the visual impacts of AMD and is responsible for as ...

The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

Geographic atrophy (GA), the late stage of age-related macular degeneration (AMD), may lead to vision loss. Here’s what to expect as the condition progresses. About 1 million people in the ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...

The phase 1b trial will enrol patients with geographic atrophy secondary to age-related macular degeneration (AMD), a leading cause of blindness. While there are multiple therapies available for ...